Calla Lily Clinical Care Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Seed
  • (In Progress)

  • Latest Deal Amount
  • $3.24M

  • Investors
  • 8

Calla Lily Clinical Care General Information

Description

Developer of an intravaginal drug delivery platform designed to improve therapeutic administration for women's health and other medical applications. The company offers a proprietary drug-device combination platform supporting applications in miscarriage prevention, in vitro fertilization support, menopause, oncology, infectious diseases, and live biotherapeutics, enabling pharmaceutical companies and healthcare providers to enhance drug delivery, expand treatment options, and extend the lifecycle of existing therapies.

Contact Information

Website
www.callali.ly
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5th Floor Charles House
  • 108-110 Finchley Road
  • London NW3 5JJ
  • England, United Kingdom
+44 020
Primary Industry
Drug Delivery
Other Industries
Other Devices and Supplies
Outcome Management (Healthcare)
Other Healthcare Technology Systems
Corporate Office
  • 5th Floor Charles House
  • 108-110 Finchley Road
  • London NW3 5JJ
  • England, United Kingdom
+44 020

Calla Lily Clinical Care Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Calla Lily Clinical Care Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Seed Round 21-Apr-2025 $3.24M In Progress Clinical Trials - Phase 2
10. Later Stage VC 20-Nov-2025 Completed Generating Revenue
9. Accelerator/Incubator 19-Jan-2026 Completed Clinical Trials - Phase 2
8. Grant 03-Apr-2025 Completed Clinical Trials - Phase 2
7. Accelerator/Incubator 25-Mar-2025 Completed Clinical Trials - Phase 1
6. Seed Round 30-Jan-2025 Completed Clinical Trials - Phase 1
5. Accelerator/Incubator 17-Jun-2024 Completed Clinical Trials - Phase 1
4. Angel (individual) 20-Mar-2024 Completed Pre-Clinical Trials
3. Grant 31-Mar-2023 $849K $576K Completed Pre-Clinical Trials
2. Angel (individual) 31-Oct-2022 $576K $576K Completed Pre-Clinical Trials
To view Calla Lily Clinical Care’s complete valuation and funding history, request access »

Calla Lily Clinical Care Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary 3,441,885 $0.000013 $0.15 $0.15 1x $0.15 9.15%
Ordinary 6,558,115 $0.000013 $0.1 $0.1 1x $0.1 17.43%
To view Calla Lily Clinical Care’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Calla Lily Clinical Care Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an intravaginal drug delivery platform designed to improve therapeutic administration for women's health an
Drug Delivery
London, United Kingdom
17 As of 2026

Darmstadt, Germany
 

London, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Calla Lily Clinical Care Competitors (2)

One of Calla Lily Clinical Care’s 2 competitors is Merck, a Corporation company based in Darmstadt, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Merck Corporation Darmstadt, Germany
L.D. Collins & Co. Corporation London, United Kingdom
You’re viewing 2 of 2 competitors. Get the full list »

Calla Lily Clinical Care Patents

Calla Lily Clinical Care Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026109544-A1 Sample collection devices Pending 19-Nov-2024
GB-202417014-D0 Sample collections devices Pending 19-Nov-2024
GB-2702541-A Sample collections devices Pending 19-Nov-2024
EP-4090517-A1 Devices for insertion into a vaginal or rectal cavity Pending 16-Dec-2019
GB-2590902-B Devices for insertion into a vaginal or rectal cavity Active 16-Dec-2019 B29C65/7882
To view Calla Lily Clinical Care’s complete patent history, request access »

Calla Lily Clinical Care Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Calla Lily Clinical Care Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ignite Healthcare Network Accelerator/Incubator
Springboard Enterprises Accelerator/Incubator
Corner Capital Management Venture Capital Minority
Embryo Ventures Venture Capital Minority
Odin Investments PE/Buyout Minority
You’re viewing 5 of 8 investors. Get the full list »

Calla Lily Clinical Care FAQs

  • When was Calla Lily Clinical Care founded?

    Calla Lily Clinical Care was founded in 2021.

  • Where is Calla Lily Clinical Care headquartered?

    Calla Lily Clinical Care is headquartered in London, United Kingdom.

  • What is the size of Calla Lily Clinical Care?

    Calla Lily Clinical Care has 17 total employees.

  • What industry is Calla Lily Clinical Care in?

    Calla Lily Clinical Care’s primary industry is Drug Delivery.

  • Is Calla Lily Clinical Care a private or public company?

    Calla Lily Clinical Care is a Private company.

  • What is Calla Lily Clinical Care’s current revenue?

    The current revenue for Calla Lily Clinical Care is .

  • How much funding has Calla Lily Clinical Care raised over time?

    Calla Lily Clinical Care has raised $6.87M.

  • Who are Calla Lily Clinical Care’s investors?

    Ignite Healthcare Network, Springboard Enterprises, Corner Capital Management, Embryo Ventures, and Odin Investments are 5 of 8 investors who have invested in Calla Lily Clinical Care.

  • Who are Calla Lily Clinical Care’s competitors?

    Merck and L.D. Collins & Co. are competitors of Calla Lily Clinical Care.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process